SCHEMBL17757494

SCHEMBL17757494

CNc1ccccc1CNC1=Nc2ccccc2NC12CCOCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17757113 0.89 ACAT2 (0.33) —
SCHEMBL17992070 0.88 — —
SCHEMBL17757738 0.88 ACAT2 (0.38) —
SCHEMBL17757094 0.87 — —
SCHEMBL19523188 0.87 STAT6 (0.38) —
SCHEMBL17757340 0.87 CYP2A13 (0.36) —
SCHEMBL17757325 0.85 PIK3CA (0.39) —
SCHEMBL17757324 0.84 CYP2A13 (0.36) —
SCHEMBL17758060 0.84 STAT6 (0.32) —
SCHEMBL17757337 0.84 CYP2A13 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016075137-A1 SPIROPYRAZINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2016-05-19 — — WO disclosed
Send feedback